Also, the 465-residue E3 ubiquitin ligase parkin is covalently modified by dopamine becoming insoluble, leading to ubiquitin E2 ligase inactivation, in the SN, with catechol-“mutated” parkin being observed in patients with PD, but not in other regions of the brain [149]. Here, PRKN is linked to Parkinson disease.